Clinical and genetic characteristics of Japanese Burkitt lymphomas with or without leukemic presentation

International Journal of Hematology

Volumn 77, Issue 5, 2003, Pages 490-498

  Namiki, Takeshi ^a   Sakashita, Akiko ^a   Kobayashi, Hirofumi ^a   Maseki, Nobuo ^a   Izumo, Toshiyuki ^a   Komada, Yoshihiro ^b   Koizumi, Shoichi ^c   Shikano, Takaaki ^d   Kikuta, Atsushi ^e   Watanabe, Arata ^f   Suzumiya, Junji ^g   Kikuchi, Masahiro ^g   Kanekoa, Yasuhiko ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b MIE UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d KOHNAN HOSPITAL   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f AKITA UNIVERSITY   (Japan)

^g FUKUOKA UNIVERSITY   (Japan)

Author keywords

ALL L3; Burkitt lymphoma; EBV; MYC; TP53

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN PRESENTATION; ARTICLE; BURKITT LYMPHOMA; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION 8; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; SOUTHERN BLOTTING;

EID: 0038685225     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02986618     Document Type: Article

References (30)

1. Magrath IT. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res. 1990;55:133-270.
2. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosome breakpoint location in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood. 1991;77:1516-1526.
3. Akasaka T, Muramatsu M, Ohno H, et al. Application of long-distance polymerase chain reaction to detection of junctional sequence created by chromosomal translocation in mature B-cell neoplasms. Blood. 1996;88:985-994.
4. Gutierrez MI, Bhatia K, Barriga F, et al. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood. 1992;79:3261-3266.
5. Saglio G, Borrello MG, Guerrasio A, et al. Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation. Genes Chromosomes Cancer. 1993;8:1-7.
6. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias: French-American-British (FAB) co-operative group. Br J Haematol. 1976;33:451-458.
7. Diebold J, Jaffe ES, Raphael M, et al. Burkitt lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2001:181-184.
8. Preudhomme C, Dervite I, Wattel E, et al. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J Clin Oncol. 1995;13:812-820.
9. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-339.
10. Kobayashi H, Maseki N, Homma C, Sakurai M, Kaneko Y. Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia. 1994;8:1944-1950.
11. Mitelman F, ed. ISCN 1995: An International System for Human Cytogenetic Nomenclature 1995. Basel, Switzerland: S. Karger AG; 1995.
12. Siebert R, Matthiesen P, Harder S, et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood. 1998;91:984-990.
13. Taya Y, Hosogai K, Hirohashi S, et al. A novel combination of K-ras and c-myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J. 1984;3:2943-2946.
14. Kobayashi H, Satake N, Maseki N, Sakashita A, Kaneko Y. The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. Br J Haematol. 1996;94:105-111.
15. Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T, Kaneko Y. Analysis of the p16INK4, p14ARF, p15, TP53 and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet. 2000;120:91-98.
16. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P. Structure of the human immunoglobulin μ locus: characterization of embryonic and rearranged J and D genes. Cell. 1981;27:583-591.
17. Zakut-Houri R, Bienz-Tadmor B, Givol D, Oren M. Human p53 cellular tumor antigen: cDNA sequence and expression in GOS cells. EMBO J. 1985;4:1251-1255.
18. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Cardon DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
19. Mills FC, Brooker JS, Camerini-Otero D. Sequences of human immunoglobulin switch regions: implications for recombination and transcription. Nucleic Acids Res. 1990;18:7305-7316.
20. Batova A, Diccianni MB, Nobori T, et al. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 1997;57:832-836.
21. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986;47:883-889.
22. Salto I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren syndrome. J Exp Med. 1989;169:2191-2198.
23. Hoelzer D, Ludwig WD, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood. 1996;87:495-508.
24. Magrath I, Adde M, Shad A, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925-934.
25. Ichikawa A, Kinoshita T, Watanabe T, et al. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med. 1997;337:529-534.
26. Ichikawa A. Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma. Int J Hematol. 2000;71:211-220.
27. Wattel E, Preudhomme C, Hecquet B, et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood. 1994;84:3148-3157.
28. INK4B gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia. Blood. 1999;93:2380-2385.
29. INK4A gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood. 1998;91:2977-2984.
30. Kaneko Y, Rowley JD, Check I, Variakojis D, Moohr JW. The 14q+ chromosome in pre-B-ALL. Blood. 1980;56:782-785.